Use of a COX-2 inhibitor for the treatment of a COX-2 dependent disorder in a patient not carrying HLA alleles associated with hepatotoxicity

Details for Australian Patent Application No. 2009282901 (hide)

Owner Novartis AG

Inventors Lewitzky, Steven; Meyer, Joanne; Paulding, Charles; Singer, Jonathan Benjamin

Agent Davies Collison Cave

Pub. Number AU-A-2009282901

PCT Pub. Number WO2010/022211

Priority 61/211,698 02.04.09 US; 61/091,081 22.08.08 US

Filing date 20 August 2009

Wipo publication date 25 February 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/022211 Priority application(s): WO2010/022211

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282906-Foldable golf bag cart

2009282898-Crosslinked polymer composition